Discovery of multi-dimensional modules by integrative analysis of cancer genomic data

Nucleic Acids Research

Volumn 40, Issue 19, 2012, Pages 9379-9391

  Zhang, Shihua ^a,b   Liu, Chun Chi ^c   Li, Wenyuan ^a   Shen, Hui ^a   Laird, Peter W ^a   Zhou, Xianghong Jasmine ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHINESE ACADEMY OF SCIENCES   (China)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENTACTIN; MESSENGER RNA; MICRORNA;

AGE DISTRIBUTION; ARTICLE; CANCER CELL; CANCER GENETICS; CELL ACTIVITY; CLINICAL ASSESSMENT; CONCEPTUAL FRAMEWORK; CORRELATION ANALYSIS; DATA ANALYSIS; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC DATABASE; GENETIC MARKER; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; JOINT MATRIX FACTORIZATION; MOLECULAR MECHANICS; MULTIDIMENSIONAL MODULE; OVARY CANCER; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RNA ANALYSIS; RNA METHYLATION; SURVIVAL RATE; TUMOR GENE;

DNA METHYLATION; FEMALE; GENOMICS; HUMANS; MICRORNAS; NEOPLASMS; OVARIAN NEOPLASMS; SURVIVAL ANALYSIS; TRANSCRIPTOME;

EID: 84868152524     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks725     Document Type: Article

References (56)

1. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
2. Weinstein, J.N., Myers, T.G., O'Connor, P.M., Friend, S.H., Fornace, A.J. Jr, Kohn, K.W., Fojo, T., Bates, S.E., Rubinstein, L.V., Anderson, N.L. et al. (1997) An information-intensive approach to the molecular pharmacology of cancer. Science, 275, 343-349. (Pubitemid 27051604)
3. Bussey, K.J., Chin, K., Lababidi, S., Reimers, M., Reinhold, W.C., Kuo, W.L., Gwadry, F., Ajay., Kouros-Mehr, H., Fridlyand, J. et al. (2006) Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol. Cancer Ther., 5, 853-867. (Pubitemid 43724584)
4. Scherf, U., Ross, D.T., Waltham, M., Smith, L.H., Lee, J.K., Tanabe, L., Kohn, K.W., Reinhold, W.C., Myers, T.G., Andrews, D.T. et al. (2000) A gene expression database for the molecular pharmacology of cancer. Nat. Genet., 24, 236-244. (Pubitemid 30132190)
5. Staunton, J.E., Slonim, D.K., Coller, H.A., Tamayo, P., Angelo, M.J., Park, J., Scherf, U., Lee, J.K., Reinhold, W.O., Weinstein, J.N. et al. (2001) Chemosensitivity prediction by transcriptional profiling. Proc. Natl Acad. Sci. USA, 98, 10787-10792. (Pubitemid 32878698)
6. Shankavaram, U.T., Reinhold, W.C., Nishizuka, S., Major, S., Morita, D., Chary, K.K., Reimers, M.A., Scherf, U., Kahn, A., Dolginow, D. et al. (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol. Cancer Ther., 6, 820-832. (Pubitemid 46554552)
7. Zhang, W., Zhu, J., Schadt, E.E. and Liu, J.S. (2010) A Bayesian partition method for detecting pleiotropic and epistatic eQTL modules. PLoS Comput. Biol., 6, e1000642.
8. Gao, F., Foat, B.C. and Bussemaker, H.J. (2004) Defining transcriptional networks through integrative modeling of mRNA expression and transcription factor binding data. BMC Bioinformatics, 5, 31.
9. Fagan, A., Culhane, A.C. and Higgins, D.G. (2007) A multivariate analysis approach to the integration of proteomic and gene expression data. Proteomics, 7, 2162-71. (Pubitemid 47067202)
10. Kutalik, Z., Beckmann, J.S. and Bergmann, S. (2008) A modular approach for integrative analysis of large-scale gene-expression and drug-response data. Nat. Biotechnol., 26, 531-539. (Pubitemid 351668039)
11. Kim, P.M. and Tidor, B. (2003) Subsystem identification through dimensionality reduction of large-scale gene expression data. Genome Res., 13, 1706-1718. (Pubitemid 36874488)
12. Brunet, J.P., Tamayo, P., Golub, T.R. and Mesirov, J.P. (2004) Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl Acad. Sci. USA, 101, 4164-4169. (Pubitemid 38405900)
13. Badea, L. (2007) Combining gene expression transcription factor regulation data using simultaneous non-negative matrix factorization. In: Proceedings of the BIOCOMP07. CSREA Press, Las Vegas, Nevada, USA.
14. Badea, L. (2008) Extracting gene expression profiles common to colon and pancreatic adenocarcinoma using simultaneous non-negative matrix factorization. Pac. Symp. Biocomput., pp. 267-278.
15. Zhang, S., Li, Q., Liu, J. and Zhou, X.J. (2011) A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics, 27, i401-i409.
16. Paatero, P. and Tapper, U. (1994) Positive matrix factorization: a non-negative factor model with optimal utilization of error estimates of data values. Environmetrics, 5, 111-126.
17. Lee, D.D. and Seung, H.S. (1999) Learning the parts of objects by non-negative matrix factorization. Nature, 401, 788-791.
18. Lee, D. and Seung, H. (2001) Algorithms for non-negative matrix factorization. Adv. Neural Inform. Process. Syst., 13, 556-562.
19. Shahnaz, F., Berry, M., Pauca, P. and Plemmons, R. (2006) Document clustering using non-negative matrix factorization. J. Inform. Process. Manage., 42, 373-386. (Pubitemid 41394167)
20. Paschou, P., Ziv, E., Burchard, E.G., Choudhry, S., Rodriguez-Cintron, W., Mahoney, M.W. and Drineas, P. (2007) PCA-correlated SNPs for structure identification in worldwide human populations. PLoS Genet., 3, e160.
21. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183. (Pubitemid 38337497)
22. Kwon, M.J. and Shin, Y.K. (2011) Epigenetic regulation of cancer-associated genes in ovarian cancer. Int. J. Mol. Sci., 12, 983-1008.
23. Madeira, S.C. and Oliveira, A.L. (2004) Biclustering algorithms for biological data analysis: a survey. IEEE Trans. Comput. Biol. Bioinform., 1, 24-45.
24. Shen, R., Olshen, A.B. and Ladanyi, M. (2009) Integrative Clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics, 25, 2906-2912.
25. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29. (Pubitemid 30257031)
26. Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D.J., Campan, M., Young, J. and Jacobs, I. (2007) Epigenetic stem cell signature in cancer. Nat. Genet., 39, 157-158. (Pubitemid 46184343)
27. Yamamura, S., Matsumura, N., Mandai, M., Huang, Z., Oura, T., Baba, T., Hamanishi, J., Yamaguchi, K., Kang, H.S., Okamoto, T. et al. (2012) The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. Int. J. Cancer, 130, 20-28.
28. Chou, J.L., Chen, L.Y., Lai, H.C. and Chan, M.W. (2010) TGF-b: friend or foe? The role of TGF-b/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy. Expert. Opin. Ther. Targets, 14, 1213-1223.
29. Bhattacharya, R., Kwon, J., Ali, B., Wang, E., Patra, S., Shridhar, V. and Mukherjee, P. (2008) Role of hedgehog signaling in ovarian cancer. Clin. Cancer Res., 14, 7659-7666.
30. Rapberger, R., Perco, P., Sax, C., Pangerl, T., Siehs, C., Pils, D., Bernthaler, A., Lukas, A., Mayer, B. and Krainer, M. (2008) Linking the ovarian cancer transcriptome and immunome. BMC Syst. Biol., 2, 2.
31. Marks, J.R., Davidoff, A.M., Kerns, B.J., Humphrey, P.A., Pence, J.C., Dodge, R.K., Iglehart, J.D., Bast, R.C. Jr and Berchuck, A. (1991) Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res., 51, 2979-2984.
32. Dinulescu, D.M., Ince, T.A., Quade, B.J., Shafer, S.A., Crowley, D. and Jacks, T. (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med., 11, 63-70. (Pubitemid 40215839)
33. Kuk, C., Gunawardana, C.G., Soosaipillai, A., Kobayashi, H., Li, L., Zheng, Y. and Diamandis, E.P. (2010) Nidogen-2: a new serum biomarker for ovarian cancer. Clin. Biochem., 43, 355-361.
34. Ulazzi, L., Sabbioni, S., Miotto, E., Veronese, A., Angusti, A., Gafà , R., Manfredini, S., Farinati, F., Sasaki, T., Lanza, G. et al. (2007) Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. Mol. Cancer, 6, 17.
35. Renard, I., Joniau, S., van Cleynenbreugel, B., Collette, C., Naômè, C., Vlassenbroeck, I., Nicolas, H., de Leval, J., Straub, J., van Criekinge, W. et al. (2010) Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples. Eur. Urol., 58, 96-104.
36. Lai, K.W., Koh, K.X., Loh, M., Tada, K., Subramaniam, M.M., Lim, X.Y., Vaithilingam, A., Salto-Tellez, M., Iacopetta, B., Ito, Y. et al. (2010) MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur. J. Cancer, 46, 1456-1463.
37. Ma, S., Tang, K.H., Chan, Y.P., Lee, T.K., Kwan, P.S., Castilho, A., Ng, I., Man, K., Wong, N., To, K.F. et al. (2010) MiR-130b promotes CD133? tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell, 7, 694-707.
38. Lui, W.O., Pourmand, N., Patterson, B.K. and Fire, A. (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res., 67, 6031-6043. (Pubitemid 47037482)
39. Reimer, D., Hubalek, M., Riedle, S., Skvortsov, S., Erdel, M., Concin, S., Fiegl, H., Müller-Holzner, E., Marth, C., Illmensee, K. et al. (2010) E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer. Cancer Res., 70, 4613-4623.
40. Siu, M.K., Chan, H.Y., Kong, D.S., Wong, E.S., Wong, O.G., Ngan, H.Y., Tam, T.F., Zhang, H., Li, Z., Chan, Q.K. et al. (2010) p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc. Natl Acad. Sci. USA, 107, 18622-18627.
41. Diehl, J.A. (2002) Cycling to cancer with cyclin D1. Cancer Biol. Ther., 1, 226-231.
42. Musgrove, E.A., Caldon, C.E., Barraclough, J., Stone, A. and Sutherland, R.L. (2011) Cyclin D as a therapeutic target in cancer. Nat. Rev. Cancer, 11, 558-572.
43. Wendt, M.K., Tian, M. and Schiemann, W.P. (2012) Deconstructing the mechanisms and consequences of TGF-b-induced EMT during cancer progression. Cell Tissue Res., 347, 85-101.
44. Kim, H., Watkinson, J., Varadan, V. and Anastassiou, D. (2010) Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med. Genomics, 3, 51.
45. Mees, S.T., Mardin, W.A., Wendel, C., Baeumer, N., Willscher, E., Senninger, N., Schleicher, C., Colombo-Benkmann, M. and Haier, J. (2010) EP300-a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int. J. Cancer, 126, 114-124.
46. Kang, Y. (2006) Pro-metastasis function of TGFbeta mediated by the Smad pathway. J. Cell Biochem., 98, 1380-1390. (Pubitemid 44141845)
47. Kakonen, S.M., Selander, K.S., Chirgwin, J.M., Yin, J.J., Burns, S., Rankin, W.A., Grubbs, B.G., Dallas, M., Coi, Y. and Quise, T.A. (2002) Transforming growth factor-b stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J. Biol. Chem., 277, 24571-24578. (Pubitemid 34951984)
48. Kang, Y., He, W., Tulley, S., Gupta, G.P., Serganova, I., Chen, C.R., Manova-Todorova, K., Blasberg, R., Gerald, W.L. and Massaqué , J. (2005) Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad Sci. USA., 102, 13909-13914. (Pubitemid 41377677)
49. Edson, M.A., Nalam, R.L., Clementi, C., Franco, H.L., Demayo, F.J., Lyons, K.M., Pangas, S.A. and Matzuk, M.M. (2010) Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol. Endocrinol., 24, 1251-1266.
50. Gaubatz, S., Lindeman, G.J., Ishida, S., Jakoi, L., Nevins, J.R., Livingston, D.M. and Rempel, R.E. (2000) E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol. Cell, 6, 729-735.
51. Matsumura, N., Huang, Z., Mori, S., Baba, T., Fujii, S., Konishi, I., Iversen, E.S., Berchuck, A. and Murphy, S.K. (2011) Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer. Genome Res., 21, 74-82.
52. Nam, E.J., Yoon, H., Kim, S.W., Kim, H., Kim, Y.T., Kim, J.H., Kim, J.W. and Kim, S. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clini. Cancer Res., 14, 2690-2695.
53. Zhang, L., Volinia, S., Bonome, T., Calin, G.A., Greshock, J., Yang, N., Liu, C.G., Giannakakis, A., Alexiou, P. et al. (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc. Natl Acad. Sci. USA, 105, 7004-7009. (Pubitemid 351754520)
54. Dahiya, N. and Morin, P.J. (2010) MicroRNAs in ovarian carcinomas. Endocr. Relat. Cancer, 17, F77-89.
55. Iorio, M.V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C.G., Alder, H. et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res., 67, 8699-8707. (Pubitemid 47437445)
56. Bast, R.C. Jr, Hennessy, B. and Mills, G.B. (2009) The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer, 9, 415-428.